Globe Life (NYSE:GL) CFO Sells $4,580,577.00 in Stock

Globe Life Inc. (NYSE:GL) CFO Thomas Peter Kalmbach sold 25,650 shares of Globe Life stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total transaction of $4,580,577.00. Following the completion of the sale, the chief financial officer owned 50,568 shares of the company’s stock, valued at approximately $9,030,433.44. This trade represents a 33.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Thomas Peter Kalmbach also recently made the following trade(s):

• On Thursday, July 30th, Thomas Peter Kalmbach sold 21,000 shares of Globe Life stock. The shares were sold at an average price of $180.06, for a total transaction of $3,781,260.00.
• On Friday, May 22nd, Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock. The shares were sold at an average price of $156.59, for a total transaction of $1,242,698.24.
• On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The stock was sold at an average price of $156.61, for a total transaction of $1,864,128.83.
• On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The stock was sold at an average price of $152.02, for a total transaction of $1,792,315.80.
• On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The stock was sold at an average price of $153.65, for a total transaction of $2,402,625.05.

Globe Life Stock Down 0.5%

NYSE:GL opened at $182.14 on Friday. The company has a market capitalization of $14.14 billion, a price-to-earnings ratio of 12.09 and a beta of 0.47. Globe Life Inc. has a one year low of $127.85 and a one year high of $191.55. The stock has a 50-day simple moving average of $171.52 and a 200 day simple moving average of $154.26. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.73%. The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the firm earned $3.05 earnings per share. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Sell-side analysts predict that Globe Life Inc. will post 15.7 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on GL shares. Truist Financial lifted their price objective on shares of Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, April 24th. JPMorgan Chase & Co. raised their price target on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. Piper Sandler lifted their price target on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Morgan Stanley boosted their price objective on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. Finally, Jefferies Financial Group increased their price objective on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $191.67.

Hedge Funds Weigh In On Globe Life

Hedge funds and other institutional investors have recently made changes to their positions in the business. Compound Planning Inc. grew its position in Globe Life by 4.3% in the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after buying an additional 82 shares in the last quarter. Root Financial Partners LLC raised its position in shares of Globe Life by 23.3% during the 1st quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock worth $61,000 after buying an additional 83 shares in the last quarter. Transcend Capital Advisors LLC lifted its stake in shares of Globe Life by 3.9% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after acquiring an additional 84 shares during the period. Natural Investments LLC lifted its stake in shares of Globe Life by 2.6% in the 4th quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock worth $482,000 after acquiring an additional 87 shares during the period. Finally, Parallel Advisors LLC boosted its holdings in shares of Globe Life by 5.6% in the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after acquiring an additional 87 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.